Loading…
SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Also known as: LABORATOIRE HRA-PHARMA
Firm Income Reported for This Client
$250K
Not substituted for client expenses
Summary
LABORATOIRE HRA PHARMA is an organization. Its political footprint includes $250K in lobbying-firm income reported for this client. Lobbying activity focuses on Health Issues. Political activity spans from 2017 to 2019.